• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.

作者信息

Vener K J

出版信息

Fed Proc. 1985 Aug;44(11):2679-84.

PMID:4018273
Abstract

A review of the 356 disapproved Small Business Innovation Research (SBIR) proposals submitted to the National Institutes of Health (NIH) for fiscal year 1983 funding was undertaken to identify the most common shortcomings of those disapproved applications. The shortcomings were divided into four general classes by using the scheme developed by other authors when describing the reasons for the disapproval of regular NIH research applications. Comparison of the reasons for disapproval of SBIR applications with regular applications suggests comparable difficulties in the areas of the problem and the approach. There is some indication, however, that the SBIR proposals may have been weaker in the category of the principal investigator (PI). In general, it is the responsibility of the PI to demonstrate that the work is timely and can be performed with available technology and expertise, and that the guidelines for the NIH SBIR program have been satisfied.

摘要

相似文献

1
National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.
Fed Proc. 1985 Aug;44(11):2679-84.
2
SBIR program. Researchers fight against bigger slice to small business.小企业创新研究计划。研究人员为小企业争取更大份额而斗争。
Science. 2009 Jul 3;325(5936):18. doi: 10.1126/science.325_18.
3
Analysis of SBIR phase I and phase II review results at the National Institutes of Health.美国国立卫生研究院小企业创新研究计划第一阶段和第二阶段评审结果分析。
FASEB J. 1991 Sep;5(12):2640-4. doi: 10.1096/fasebj.5.12.1916087.
4
Summary statements of the NIH Nursing Research Grant Applications.美国国立卫生研究院护理研究资助申请摘要声明。
Nurs Res. 1991 Nov-Dec;40(6):346-51.
5
The National Institutes of Health Small Business Innovation Research (SBIR) Program: opportunities for orphan drug development.美国国立卫生研究院小型企业创新研究(SBIR)计划:罕见病药物开发的机遇。
Prog Clin Biol Res. 1985;197:25-30.
6
National institutes of health funding for surgical research.美国国立卫生研究院对手术研究的资助。
Ann Surg. 2008 Feb;247(2):217-21. doi: 10.1097/SLA.0b013e3181568e26.
7
Understanding the NIH review process: a brief guide to writing grant proposals in neurotoxicology.了解美国国立卫生研究院的评审过程:神经毒理学领域资助申请书撰写简要指南
Neurotoxicology. 1999 Feb;20(1):91-7.
8
Merit, quality, and the SBIR program.优点、质量与小企业创新研究计划。
Science. 1996 Jun 21;272(5269):1725.
9
The sad and bleak future for urology funding at the National Institutes of Health.美国国立卫生研究院泌尿外科研究经费的黯淡前景。
Urol Clin North Am. 2009 Feb;36(1):85-93, vii. doi: 10.1016/j.ucl.2008.08.008.
10
Nursing research grant proposals: what influenced their approval or disapproval in two national granting agencies.
Nurs Res. 1973 Jul-Aug;22(4):292-9.